HCL

Tepha, Inc is a cutting-edge company based in Lexington, MA that specializes in developing innovative biomaterials for medical applications. With a focus on research and development, Tepha, Inc is dedicated to creating advanced solutions to address critical healthcare challenges. Generated from their business information

Cyteir is a clinical-stage oncology company dedicated to the development of CYT-0851, an oral investigational drug designed to inhibit monocarboxylate transporters. The company's current focus is on advancing CYT-0851 in combination with capecitabine and gemcitabine through a Phase 1/2 clinical study targeting patients with advanced ovarian cancer. With a pipeline of novel drug candidates aimed at addressing key vulnerabilities in cancer, Cyteir is committed to pioneering therapeutic solutions for patients in need. Their approach emphasizes leveraging cancer's vulnerabilities as a strength in treatment development. Generated from the website

Kiniksa Pharmaceuticals is a biopharmaceutical company dedicated to addressing critical therapeutic needs for patients suffering from debilitating diseases. With a focus on immunemodulating assets, Kiniksa approaches its mission with a sense of urgency, understanding that every moment counts in the pursuit of better health outcomes. Headquartered in Lexington, Massachusetts, Kiniksa operates internationally with locations in the United Kingdom and Switzerland. The company emphasizes patient advocacy and strives to make every second matter in the development of innovative treatments for conditions such as recurrent pericarditis. Generated from the website